About
ProtonIntel develops CKM™, an investigational wearable device with a minimally invasive sensor placed under the skin to continuously monitor potassium levels, providing clinicians with real-time data to manage cardio-kidney diseases such as heart failure and chronic kidney disease.
Explore ProtonIntel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.